Praxis Precision Medicines, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
27.9M
on 2026-06-30, from 13.3M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
S-3ASR of 2024-12-23. Not read yet. S-3ASR ↗
$250.0M
TD Securities (USA), agreement of 2025-09-05. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
The 10-Q filed 2026-08-06 is not read yet.
Cash
9.9 quarters
$758.6M on 2026-06-30 ÷ $76.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-01-06 | Public offering | 2,212,000 | $260.00 | $575.1M | 424B5 ↗ |
| 2025-10-16 | Public offering incl. 0.32M pre-funded | 3,343,950 | $157.00 | $525.0M | 424B5 ↗ |